First Time Loading...

Hikma Pharmaceuticals PLC
LSE:HIK

Watchlist Manager
Hikma Pharmaceuticals PLC Logo
Hikma Pharmaceuticals PLC
LSE:HIK
Watchlist
Price: 1 994 GBX 0.66% Market Closed
Updated: May 12, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Income Statement

2.9B
+5%
Revenue
Growth Rates:
1 Year
+14%
3 Years
+23%
5 Years
+38%
7 Years
+47%
10 Years
+111%
622m
+1%
Operating Income
Growth Rates:
1 Year
+22%
3 Years
+18%
5 Years
+39%
7 Years
+48%
10 Years
+77%
190m
+30%
Net Income
Growth Rates:
1 Year
+1%
3 Years
-56%
5 Years
-33%
7 Years
+23%
10 Years
-10%

Earnings Waterfall
Hikma Pharmaceuticals PLC

Revenue
2.9B USD
Cost of Revenue
-1.5B USD
Gross Profit
1.4B USD
Operating Expenses
-785m USD
Operating Income
622m USD
Other Expenses
-432m USD
Net Income
190m USD

Income Statement
Hikma Pharmaceuticals PLC

Rotate your device to view
Income Statement
Currency: USD
Dec-2005 Jun-2006 Dec-2006 Jun-2007 Dec-2007 Jun-2008 Dec-2008 Jun-2009 Dec-2009 Jun-2010 Dec-2010 Jun-2011 Dec-2011 Jun-2012 Dec-2012 Jun-2013 Dec-2013 Jun-2014 Dec-2014 Jun-2015 Dec-2015 Jun-2016 Dec-2016 Jun-2017 Dec-2017 Jun-2018 Dec-2018 Jun-2019 Dec-2019 Jun-2020 Dec-2020 Jun-2021 Dec-2021 Jun-2022 Dec-2022 Jun-2023 Dec-2023
Revenue
Revenue
262
N/A
285
+9%
317
+11%
387
+22%
449
+16%
524
+17%
581
+11%
602
+4%
637
+6%
673
+6%
731
+9%
768
+5%
918
+20%
1 056
+15%
1 109
+5%
1 215
+10%
1 365
+12%
1 465
+7%
1 489
+2%
1 460
-2%
1 440
-1%
1 613
+12%
1 950
+21%
1 963
+1%
1 936
-1%
2 020
+4%
2 076
+3%
2 130
+3%
2 203
+3%
2 292
+4%
2 341
+2%
2 425
+4%
2 553
+5%
2 550
0%
2 517
-1%
2 731
+9%
2 875
+5%
Gross Profit
Cost of Revenue
(126)
(142)
(158)
(195)
(227)
(281)
(324)
(330)
(332)
(341)
(374)
(417)
(523)
(599)
(605)
(592)
(601)
(613)
(638)
(650)
(622)
(746)
(932)
(938)
(963)
(1 008)
(1 004)
(1 019)
(1 108)
(1 139)
(1 128)
(1 198)
(1 252)
(1 242)
(1 252)
(1 356)
(1 468)
Gross Profit
136
N/A
143
+5%
159
+11%
193
+21%
222
+15%
243
+10%
257
+6%
273
+6%
304
+12%
332
+9%
357
+8%
351
-2%
395
+12%
457
+16%
504
+10%
623
+24%
764
+23%
852
+11%
851
0%
810
-5%
818
+1%
867
+6%
1 018
+17%
1 025
+1%
973
-5%
1 012
+4%
1 072
+6%
1 111
+4%
1 095
-1%
1 153
+5%
1 213
+5%
1 227
+1%
1 301
+6%
1 308
+1%
1 265
-3%
1 375
+9%
1 407
+2%
Operating Income
Operating Expenses
(68)
(74)
(84)
(107)
(129)
(149)
(169)
(182)
(197)
(207)
(222)
(242)
(277)
(312)
(337)
(387)
(412)
(408)
(449)
(450)
(437)
(504)
(599)
(606)
(587)
(588)
(623)
(647)
(621)
(647)
(687)
(682)
(742)
(773)
(756)
(760)
(785)
Selling, General & Administrative
(50)
(54)
(65)
(88)
(107)
(121)
(134)
(144)
(157)
(172)
(191)
(203)
(233)
(261)
(273)
(288)
(311)
(335)
(356)
(355)
(372)
(388)
(392)
(407)
(426)
(437)
(437)
(434)
(453)
(466)
(464)
(467)
(488)
(512)
(509)
(513)
(544)
Research & Development
(17)
(18)
(18)
(19)
(19)
(21)
(22)
(19)
(17)
(19)
(24)
(25)
(31)
(37)
(34)
(36)
(39)
(39)
(55)
(56)
(36)
(73)
(126)
(129)
(115)
(102)
(118)
(129)
(126)
(130)
(137)
(134)
(143)
(153)
(144)
(139)
(149)
Depreciation & Amortization
0
0
0
0
0
(4)
(7)
(7)
(7)
(7)
(7)
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
(17)
(34)
(38)
(42)
(50)
(73)
(87)
(92)
(92)
(88)
Other Operating Expenses
(2)
(2)
(1)
(1)
(3)
(3)
(6)
(11)
(16)
(9)
0
(13)
(13)
(15)
(30)
(63)
(62)
(35)
(38)
(39)
(29)
(43)
(81)
(70)
(46)
(49)
(68)
(67)
(8)
(13)
(44)
(31)
(38)
(21)
(11)
(16)
(4)
Operating Income
68
N/A
69
+1%
74
+8%
85
+15%
92
+8%
94
+1%
87
-7%
91
+5%
107
+18%
124
+16%
135
+9%
110
-19%
119
+8%
145
+22%
167
+15%
236
+41%
352
+49%
444
+26%
402
-9%
360
-10%
381
+6%
363
-5%
419
+15%
419
N/A
386
-8%
424
+10%
449
+6%
464
+3%
474
+2%
506
+7%
526
+4%
545
+4%
559
+3%
535
-4%
509
-5%
615
+21%
622
+1%
Pre-Tax Income
Interest Income Expense
(2)
0
1
(3)
(9)
(15)
(17)
(15)
(12)
(12)
(14)
(16)
(24)
(31)
(37)
(37)
(36)
(34)
(16)
(41)
(40)
(61)
(39)
(9)
43
17
(39)
(35)
(27)
(41)
(33)
(49)
(41)
(64)
(65)
(83)
(67)
Non-Reccuring Items
0
0
0
0
0
(6)
(6)
(0)
0
0
0
0
0
0
1
(14)
(19)
(6)
(6)
(6)
(9)
(71)
(158)
(171)
(1 159)
(1 130)
(104)
(38)
60
74
76
107
39
(31)
(200)
(312)
(260)
Total Other Income
(1)
(1)
0
0
0
0
0
(0)
(0)
(1)
(1)
0
(1)
(1)
1
1
1
1
(18)
0
(14)
0
(12)
(12)
(8)
(8)
(13)
(13)
(16)
0
(11)
0
(13)
0
(11)
0
(14)
Pre-Tax Income
64
N/A
68
+6%
76
+11%
83
+9%
84
+1%
74
-12%
64
-13%
75
+17%
95
+26%
112
+18%
121
+8%
93
-23%
94
+1%
112
+19%
132
+18%
186
+41%
298
+60%
405
+36%
362
-11%
313
-14%
318
+2%
231
-27%
210
-9%
227
+8%
(738)
N/A
(697)
+6%
293
N/A
378
+29%
491
+30%
539
+10%
558
+4%
603
+8%
544
-10%
440
-19%
233
-47%
220
-6%
281
+28%
Net Income
Tax Provision
(19)
(18)
(20)
(21)
(20)
(13)
(7)
(8)
(16)
(22)
(22)
(13)
(11)
(21)
(25)
(45)
(82)
(95)
(80)
(67)
(64)
(53)
(52)
(58)
(150)
(152)
(8)
(17)
(4)
(25)
(128)
(137)
(124)
(94)
(42)
(72)
(89)
Income from Continuing Operations
45
50
56
62
64
61
57
68
79
90
100
80
84
91
107
141
216
311
282
246
254
178
158
169
(888)
(849)
285
361
487
514
430
466
420
346
191
148
192
Income to Minority Interest
(1)
(1)
(2)
(2)
(2)
(1)
0
(0)
(2)
(1)
(1)
(3)
(3)
(4)
(7)
(7)
(4)
(3)
(4)
(3)
(2)
(2)
(3)
(3)
(4)
(6)
(3)
0
(1)
(1)
1
1
1
0
(3)
(2)
(2)
Net Income (Common)
44
N/A
49
+11%
55
+11%
60
+10%
63
+4%
60
-4%
57
-5%
67
+18%
78
+15%
89
+15%
99
+11%
77
-22%
80
+4%
87
+9%
100
+14%
133
+33%
212
+59%
307
+45%
278
-10%
243
-13%
252
+4%
176
-30%
155
-12%
166
+7%
(843)
N/A
(806)
+4%
282
N/A
361
+28%
486
+35%
513
+6%
431
-16%
467
+8%
421
-10%
346
-18%
188
-46%
146
-22%
190
+30%
EPS (Diluted)
0.29
N/A
0.29
N/A
0.31
+7%
0.34
+10%
0.35
+3%
0.32
-9%
0.3
-6%
0.35
+17%
0.4
+14%
0.46
+15%
0.51
+11%
0.4
-22%
0.41
+2%
0.44
+7%
0.5
+14%
0.67
+34%
1.07
+60%
1.55
+45%
1.39
-10%
1.22
-12%
1.25
+2%
0.77
-38%
0.66
-14%
0.69
+5%
-3.51
N/A
-3.33
+5%
1.17
N/A
1.49
+27%
2
+34%
2.11
+5%
1.81
-14%
2.01
+11%
1.81
-10%
1.5
-17%
0.84
-44%
0.66
-21%
0.85
+29%

See Also

Summary
HIK intrinsic value, competitors valuation, and company profile.
DCF Valuation
HIK stock valuation using Discount Cash Flow valuation method.
Relative Valuation
HIK stock valuation using valuation multiples.
Wall Street Estimates
HIK price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
HIK stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 136,400+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.